Market news — every asset we track

Assets

BOLT

Bolt Biotherapeutics CEO Quinn sells $58,402 in stock

Sep 22Investing.com

BOLT

Bolt Biotherapeutics senior VP Nemec sells $26,072 in shares

Sep 22Investing.com

BOLT

Bolt Biotherapeutics COO Grant Yonehiro sells $43,806 in company shares

Sep 22Investing.com

BOLT

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 anticipated to...

Aug 31Barchart.com

BOLT

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Misses Revenue Estimates

Aug 11ca.finance.yahoo.com

BOLT

Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 11Yahoo Finance

BOLT

Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Tenaya Therapeutics (TNYA) and Elevance Health (ELV)

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

Jul 17The Globe and Mail

This is the newest page. Registered accounts read further back.